Clinical Trial Update: JALYN for Benign Prostatic Hyperplasia (BPH) and Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS) [Phase 3]

View source ↗

Summary

Phase 3 trial of JALYN for benign prostatic hyperplasia and Chronic prostatitis/chronic pelvic pain syndrome was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia
• Prostatitis Chronic Pelvic Pain Syndrome

Drugs mentioned

• JALYN (dutasteride and tamsulosin hydrochloride)

Snippet

Sponsor: Dr. J. Curtis Nickel | Conditions: Benign Prostatic Hyperplasia, Chronic Prostatitis | Phase 3 | Status: TERMINATED